Non-resolved chronic pulmonary thromboembolism is a frequent cause of
pulmonary hypertension. In long-standing disease hypertension is progr
essive due to intimal and medial changes in the perfused vessels. Non-
resolution of thromboemboli is often associated with underlying coagul
opathies; the presence of a lupus anticoagulant may pose a significant
problem in the peri-operative management of these patients. Pulmonary
thrombendarterectomy presents an efficient option of treatment which
is feasible in the majority of patients. By means of pulmonary angiogr
aphy and computed tomography operability is verified by the often diff
icult recognition of thromboembolic changes in the central pulmonary a
rteries. Patients with solely peripheral thromboembolic changes or pri
mary pulmonary hypertension must be excluded. In presence of significa
nt exertional dyspnea and/or pulmonary pressure elevation surgery is i
ndicated. Mortality is high and mainly related to unrelieved pulmonary
hypertension or pulmonary complications; pulmonary reperfusion edema,
respiratory failure or pneumonia and sepsis. In all survivors the red
uction of pulmonary hypertension is highly significant and persistent.
Thromboembolic pulmonary hypertension may be treated curatively in mo
st patients by thrombendarterectomy. Correct selection of surgical can
didates is mandatory, and the patients should preferably be diagnosed
and undergo surgery in an early stage of their disease.